Schizophrenia and diabetes (Q34991070)

5 August 2017

1 reference

title

Schizophrenia and diabetes (English)

1 reference

5 August 2017

1 reference

David C Henderson

1

1 reference

5 August 2017

Elissa R Ettinger

series ordinal

2

1 reference

5 August 2017

publication date

1 January 2002

1 reference

International Review of Neurobiology

5 August 2017

published in

1 reference

5 August 2017

volume

51

1 reference

5 August 2017

page(s)

481-501

1 reference

Diabetic ketoacidosis and clozapine

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

The pathogenesis of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

The experimental reproduction of amphetamine psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Schizotypal symptoms in the relatives of schizophrenia patients: an empirical analysis of the factor structure

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Olanzapine-induced glucose dysregulation

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Intellectual deficits in first-episode schizophrenia: evidence for progressive deterioration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Comparison of incidence of insulin-dependent diabetes mellitus in children and young adults in the Province of Turin, Italy, 1984-91. Piedmont Study Group for Diabetes Epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Diabetic ketoacidosis associated with clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Diabetic ketoacidosis associated with risperidone treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Dopamine receptor antagonists modulate glucose uptake in rat pheochromocytoma (PC12) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Antipsychotic drugs affect glucose uptake and the expression of glucose transporters in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Genome scan of European-American schizophrenia pedigrees: Results of the NIMH genetics initiative and millennium consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Hyperglycemia associated with olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Plasma Free Fatty Acids Before and After an Intravenous Insulin Injection in Acute Schizophrenic Men

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Diabetic ketoacidosis with olanzapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

1 reference

7 January 2021

Tardive dyskinesia and substrates of energy metabolism in CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Neuropsychological assessment of monozygotic twins discordant for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Abnormalities in the thalamus and prefrontal cortex during episodic object recognition in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Neuropsychological functioning of first-episode schizophreniform patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Genetics and etiology of schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Psychotropic drugs, diabetes and chronic mental patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Psychomotor impairment and cognitive disturbances induced by neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Clozapine-associated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Ketoacidosis as a side-effect of clozapine: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Diabetic ketoacidosis associated with clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Effect of endogenous beta-hydroxybutyrate on glucose metabolism in the diabetic rabbit brain: a (13)C-magnetic resonance spectroscopy study of [U-(13)C]glucose metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Schizophrenia and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Diabetes mellitus in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Persistent tardive dyskinesia and neuroleptic effects on glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Information-processing abnormalities as neuropsychological vulnerability indicators for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Diabetic ketoacidosis from clozapine and lithium cotreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Clozapine and associated diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Cognitive function in diabetes mellitus: the effects of duration of illness and glycaemic control.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Search for schizophrenia susceptibility genes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Relationship between hyperglycemia and cognitive function in older NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

The Positive Correlation between Insulin Resistance and Duration of Hospitalization in Untreated Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

The HIV-1 protease inhibitor indinavir impairs insulin signalling in HepG2 hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Blood Sugar Levels in Patients Treated with Chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Clozapine-induced diabetic ketoacidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Dopamine receptors, neuroleptics, and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

New-onset diabetes mellitus associated with the initiation of quetiapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: a minimal model analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Phenothiazines and Diabetes in Hospitalized Women

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Schizophrenia: genes and environment

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

The case for heterogeneity in the etiology of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

A Survey for Unknown Diabetics in a Mental Hospital: I. Men under Age Fifty

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

A Survey for Unknown Diabetics in a Mental Hospital: II. Men from Age Fifty

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Novel antipsychotics and new onset diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Diabetes and development of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Using vulnerability indicators to compare conceptual models of genetic heterogeneity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Different influences of classical antipsychotics and clozapine on glucose-insulin homeostasis in patients with schizophrenia or related psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

Forms of memory failure in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2802%2951014-X

7 January 2021

10.1016/S0074-7742(02)51014-X

Identifiers

DOI

1 reference

5 August 2017

1 reference